299 related articles for article (PubMed ID: 36049486)
1. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis.
Rajasingham R; Govender NP; Jordan A; Loyse A; Shroufi A; Denning DW; Meya DB; Chiller TM; Boulware DR
Lancet Infect Dis; 2022 Dec; 22(12):1748-1755. PubMed ID: 36049486
[TBL] [Abstract][Full Text] [Related]
2. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.
Drain PK; Kleene JM; Coleman SM; Losina E; Katz JN; Giddy J; Ross D; Freedberg KA; Bassett IV
HIV Med; 2015 Nov; 16(10):640-4. PubMed ID: 25958770
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
[TBL] [Abstract][Full Text] [Related]
8. Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
Cassim N; Schnippel K; Coetzee LM; Glencross DK
PLoS One; 2017; 12(2):e0171675. PubMed ID: 28166254
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran.
Bandalizadeh Z; Shokohi T; Moosazadeh M; Keikha N; Seyedpor H; Rabie Rudsari M; Babamahmoudi F; Ghasemian R; Mardani M; Javanian M; Soleimanpour S; Sefidgar AA; Shokri M; Gouya MM; Seyedmousavi S
Curr Microbiol; 2020 Aug; 77(8):1667-1672. PubMed ID: 32296917
[TBL] [Abstract][Full Text] [Related]
12. Implementation of point-of-care testing and prevalence of cryptococcal antigenaemia among patients with advanced HIV disease in Mumbai, India.
Acharya S; Allam RR; Karanjkar VK; Rathod D; Mahajan R; Deshpande P; Palkar A; Todmal S; Koli S; Dhande S; Dale J; Yeldandi VV; Harshana A; Agarwal R; Upadhyaya S; Nyendak M
BMJ Open; 2023 Jun; 13(6):e070500. PubMed ID: 37349096
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcal infection in HIV-infected patients with CD4
Pérez-Jacoiste Asín MA; Bisbal O; Iribarren JA; Pérez-Rivilla A; Mican R; Dronda F; González-Domenech CM; Vinuesa-García D; Macías J; Lumbreras C; Moreno S; Rubio R;
Clin Microbiol Infect; 2021 Aug; 27(8):1171.e1-1171.e7. PubMed ID: 33069858
[TBL] [Abstract][Full Text] [Related]
14. Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil.
Borges MASB; de Araújo Filho JA; Oliveira BJS; Moreira IS; de Paula VV; de Bastos AL; Soares RBA; Turchi MD
PLoS One; 2019; 14(7):e0219928. PubMed ID: 31344140
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou/Benin].
Ogouyèmi-Hounto A; Zannou DM; Ayihounton G; Ahouada C; Azon-Kouanou A; Acakpo J; Sissinto Savi de Tove Y; Kinde Gazard D
J Mycol Med; 2016 Dec; 26(4):391-397. PubMed ID: 27641486
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis.
Li Y; Huang X; Chen H; Qin Y; Hou J; Li A; Wu H; Yan X; Chen Y
BMC Infect Dis; 2020 Jun; 20(1):410. PubMed ID: 32532212
[TBL] [Abstract][Full Text] [Related]
17. Preventing deaths from cryptococcal meningitis: from bench to bedside.
Roy M; Chiller T
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
19. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker
Karaman E; Ilkit M; Kuşçu F
Mycoses; 2019 Oct; 62(10):961-968. PubMed ID: 31344286
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana.
Tenforde MW; Milton T; Rulaganyang I; Muthoga C; Tawe L; Chiller T; Greene G; Jordan A; Williams CG; Owen L; Leeme TB; Boose A; Ngidi J; Mine M; Jarvis JN
Clin Infect Dis; 2021 May; 72(9):1635-1638. PubMed ID: 32604411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]